SIGA Technologies, Inc. (SIGA)
$3.28+0.00%Close
BUYRECOVERY · day 18
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $235M
- Beta
- 0.89
- Div yield
- 18.24%
- P/E (TTM)
- -75.46
- Short % float
- 8.78%
- Days to cover
- 5.2
- SI change
- -3.5%
- 1W
- -2.96%
- 1M
- +8.61%
- vs SPY 1W
- -4.12%
- vs SPY 1M
- +5.62%
Industry peers
FMP comparable companies · ranked by market cap
- VTYXVentyx Biosciences, Inc.$1.0B$14.00
- RIGLBUYRigel Pharmaceuticals, Inc.$908MBULLQ 9$49.08+0.74%
- OLMASELLOlema Pharmaceuticals, Inc.$683MCRISISQ -1$7.82+0.00%
- ESPRBUYEsperion Therapeutics, Inc.$661MBULLQ 1$3.18+0.00%
- AQSTSELLAquestive Therapeutics, Inc.$600MRECOVERYQ -4$4.78+0.42%
- CTMXSELLCytomX Therapeutics, Inc.$559MCRISISQ 7$2.57+4.05%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SIGA?
- LOPJLB’s latest quantitative signal on SIGA Technologies, Inc. (SIGA) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is SIGA in?
- SIGA Technologies, Inc. (SIGA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does SIGA Technologies, Inc. (SIGA) do?
- SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This par…